Lataa...
When fat goes down, prostate cancer is on the ropes
Reprogrammed lipid metabolism and persistent androgen receptor signaling commonly mark aggressive prostate cancer. We describe that targeting de-novo lipogenesis deprives prostate cancer cells of substrates and fuel, while inhibiting androgen receptor signaling. Our study uncovers the interplay betw...
Tallennettuna:
| Julkaisussa: | Mol Cell Oncol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6512936/ https://ncbi.nlm.nih.gov/pubmed/31131311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2019.1595308 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|